Calyxt Inc (CLXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXT | TVRD | BTAI | ||
| Company | Calyxt Inc | Tvardi Therapeutics Inc | Bioxcel Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.16 | 3.38 | 1.1200 | ||
| High | 7.77 | 3.38 | 1.2100 | ||
| Low | 6.01 | 3.15 | 1.1200 | ||
| Latest | 6.30 | 3.22 | 1.2000 | ||
| Change | +0.33 | -0.17 | +0.0500 | ||
| % Change | +5.53% | -5.01% | +4.35% | ||
| Volume | 254,600 | 29,400 | 813,100 | ||
| 20-Day Average Volume | 63,345 | 56,000 | 1,072,810 | ||
| Previous Close | 5.97 | 3.39 | 1.1500 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 4.10 | 3.17 | 1.1965 | ||
| 20-Day Raw Stochastic | 69.38% | 47.00% | 35.85% | ||
| 20-Day Relative Strength | 75.29 | 45.27 | 43.58 | ||
| Weighted Alpha | +160.70 | -33.82 | -80.18 | ||
| Today's Opinion | 100% Buy | 88% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Sell | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.05% since 05/23/23 | +5.92% since 04/13/26 | +17.65% since 04/13/26 | ||
| Low | 4.53 on 05/25/23 | 2.97 on 04/14/26 | 1.0100 on 04/14/26 | ||
| High | 7.77 on 05/31/23 | 3.50 on 04/15/26 | 1.2550 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +107.92% since 04/28/23 | -8.52% since 03/20/26 | -20.53% since 03/20/26 | ||
| Low | 2.64 on 05/01/23 | 2.75 on 04/07/26 | 1.0100 on 04/14/26 | ||
| High | 7.77 on 05/31/23 | 3.75 on 03/23/26 | 1.5400 on 03/23/26 | ||
| 3-Month | |||||
| %Chg | +49.96% since 02/28/23 | -30.45% since 01/20/26 | -36.51% since 01/20/26 | ||
| Low | 2.41 on 04/12/23 | 2.75 on 04/07/26 | 1.0100 on 04/14/26 | ||
| High | 7.77 on 05/31/23 | 4.89 on 01/22/26 | 1.9676 on 01/21/26 | ||
| 6-Month | |||||
| %Chg | +303.33% since 11/28/22 | -47.81% since 10/20/25 | -47.60% since 10/20/25 | ||
| Low | 1.32 on 12/27/22 | 2.75 on 04/07/26 | 1.0100 on 04/14/26 | ||
| High | 7.77 on 05/31/23 | 6.13 on 10/21/25 | 2.4568 on 10/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,334 | 31,803 | 31,136 | ||
| Shares Outstanding, K | 4,974 | 9,381 | 27,075 | ||
| Annual Sales | 160,000 | 0 | 640,000 | ||
| Annual Net Income | -16,890,000 | -18,210,000 | -69,900,000 | ||
| Last Quarter Sales | 40,000 | 0 | 260,000 | ||
| Last Quarter Net Income | -5,390,000 | -11,950,000 | -12,550,000 | ||
| 60-Month Beta | 2.04 | 0.16 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.09 on 05/01/23 | -0.78 on 03/31/26 | -0.58 on 03/27/26 | ||
| Latest Earnings Date | 08/03/23 | 05/12/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||